These findings were corroborated by flow cytometry, which demonstrated a marked reduction in FCER1A protein levels (p < 0.01) and a significant increase in RGS1 protein expression (p < 0.001) in the plasma of SLE patients (Figs. 7B, 7C). This evidence concerns the gene FCER1A and systemic lupus erythematosus.